Literature DB >> 16551473

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.

L A Dailey1, N Jekel, L Fink, T Gessler, T Schmehl, M Wittmar, T Kissel, W Seeger.   

Abstract

Particulate nanocarriers have been praised for their advantageous drug delivery properties in the lung, such as avoidance of macrophage clearance mechanisms and long residence times. However, instilled non-biodegradable polystyrene nanospheres with small diameters and thus large surface areas have been shown to induce pulmonary inflammation. This study examines the potential of biodegradable polymeric nanoparticles composed of poly(lactic-co-glycolic acid) (PLGA) and the novel PLGA derivative, diethylaminopropylamine polyvinyl alcohol-grafted-poly(lactic-co-glycolic acid) (DEAPA-PVAL-g-PLGA), to provoke inflammatory responses in the murine lung after intratracheal instillation. Lactate dehydrogenase (LDH) release, protein concentration, MIP-2 mRNA induction, and polymorphonucleocyte (PMN) recruitment in the bronchial alveolar lavage fluid (BALF) were used to evaluate an inflammatory response in Balb-C mice. Two sizes of polystyrene (PS) nanospheres (diameters: 75 nm and 220 nm) were included in the study for comparison. All nanoparticle suspensions were instilled at concentrations of 1 microg/microl and 2.5 microg/microl, representative of an estimated "therapeutic dose" and a concentrated "dose" of particles. In all experiments, the 75 nm PS particles exhibited elevated responses for the inflammatory markers investigated. In contrast, biodegradable particles of comparable hydrodynamic diameter showed a significantly lower inflammatory response. The most marked differences were observed in the extent of PMN recruitment. While the 75 nm and 220 nm PS nanospheres exhibited 41 and 74% PMN within the total BALF cell population after 24 h, respectively, PMN recruiting in lungs instilled with both types of biodegradable particles did not exceed values of the negative isotonic glucose control. In conclusion, evidence suggests that biodegradable polymeric nanoparticles designed for pulmonary drug delivery may not induce the same inflammatory response as non-biodegradable polystyrene particles of comparable size.

Entities:  

Mesh:

Year:  2006        PMID: 16551473     DOI: 10.1016/j.taap.2006.01.016

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  45 in total

Review 1.  Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.

Authors:  Istvan Szelenyi
Journal:  Inflamm Res       Date:  2011-11-05       Impact factor: 4.575

2.  Building membrane emulsification into pulmonary drug delivery and targeting.

Authors:  Decai Bao; Yanjun Zhao
Journal:  Pharm Res       Date:  2010-08-12       Impact factor: 4.200

Review 3.  Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.

Authors:  Lauren Willis; Don Hayes; Heidi M Mansour
Journal:  Lung       Date:  2012-01-25       Impact factor: 2.584

4.  Particulate matter in cigarette smoke increases ciliary axoneme beating through mechanical stimulation.

Authors:  Chelsea R Navarrette; Joseph H Sisson; Elizabeth Nance; Diane Allen-Gipson; Justin Hanes; Todd A Wyatt
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-01-26       Impact factor: 2.849

Review 5.  Nanoparticles: pharmacological and toxicological significance.

Authors:  C Medina; M J Santos-Martinez; A Radomski; O I Corrigan; M W Radomski
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

Review 6.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

7.  Silk Protein Bioresorbable, Drug-Eluting Ear Tubes: Proof-of-Concept.

Authors:  Sarah A Bradner; Deepa Galaiya; Nikhila Raol; David L Kaplan; Chistopher J Hartnick
Journal:  Adv Healthc Mater       Date:  2019-01-09       Impact factor: 9.933

Review 8.  Molecular imaging with nanoparticles: giant roles for dwarf actors.

Authors:  Paul Debbage; Werner Jaschke
Journal:  Histochem Cell Biol       Date:  2008-09-30       Impact factor: 4.304

Review 9.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

10.  Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders.

Authors:  Jichao Kang; Oliver Lambert; Michael Ausborn; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2008-02-14       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.